Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Samuel Leung

Showing results (101-110 of 128) with videos related to

Pageof 13
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 6, 2023
Supervised Risk Predictor of Breast Cancer Based on Intrinsic SubtypesJoel S Parker, Michael Mullins, Maggie C U Cheang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 22, 2012
Responsiveness of intrinsic subtypes to adjuvant anthracycline substitution in the NCIC.CTG MA.5 randomized trialMaggie C U Cheang, K David Voduc, Dongsheng Tu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 8, 2022
Triple-Negative PAM50 Non-Basal Breast Cancer Subtype Predicts Benefit from Extended Adjuvant CapecitabineKarama Asleh, Ana Lluch, Angela Goytain, et al.
The Journal of Pathology|August 29, 2022
The proteome of clear cell ovarian carcinomaJennifer X Ji, Dawn R Cochrane, Gian Luca Negri, et al.
Human Pathology|May 4, 2020
Proteomic analysis of transitional cell carcinoma-like variant of tubo-ovarian high-grade serous carcinomaBasile Tessier-Cloutier, Dawn R Cochrane, Anthony N Karnezis, et al.
The Journal of Pathology|September 11, 2015
Dual loss of the SWI/SNF complex ATPases SMARCA4/BRG1 and SMARCA2/BRM is highly sensitive and specific for small cell carcinoma of the ovary, hypercalcaemic typeAnthony N Karnezis, Yemin Wang, Pilar Ramos, et al.
Breast Cancer Research and Treatment|January 3, 2021
A clinical calculator to predict disease outcomes in women with triple-negative breast cancerMei-Yin C Polley, Roberto A Leon-Ferre, Samuel Leung, et al.
Cancer Research|March 19, 2011
Targeting tumor hypoxia: suppression of breast tumor growth and metastasis by novel carbonic anhydrase IX inhibitorsYuanmei Lou, Paul C McDonald, Arusha Oloumi, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|March 15, 2016
An Immunohistochemical Algorithm for Ovarian Carcinoma TypingMartin Köbel, Kurosh Rahimi, Peter F Rambau, et al.
Cancer|April 1, 2021
Evaluation of treatment effects in patients with endometrial cancer and POLE mutations: An individual patient data meta-analysisJessica N McAlpine, Derek S Chiu, Remi A Nout, et al.
Pageof 13

Showing results (101-110 of 128) with videos related to

Sort By:
Pageof 13
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 6, 2023
Supervised Risk Predictor of Breast Cancer Based on Intrinsic SubtypesJoel S Parker, Michael Mullins, Maggie C U Cheang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 22, 2012
Responsiveness of intrinsic subtypes to adjuvant anthracycline substitution in the NCIC.CTG MA.5 randomized trialMaggie C U Cheang, K David Voduc, Dongsheng Tu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 8, 2022
Triple-Negative PAM50 Non-Basal Breast Cancer Subtype Predicts Benefit from Extended Adjuvant CapecitabineKarama Asleh, Ana Lluch, Angela Goytain, et al.
The Journal of Pathology|August 29, 2022
The proteome of clear cell ovarian carcinomaJennifer X Ji, Dawn R Cochrane, Gian Luca Negri, et al.
Human Pathology|May 4, 2020
Proteomic analysis of transitional cell carcinoma-like variant of tubo-ovarian high-grade serous carcinomaBasile Tessier-Cloutier, Dawn R Cochrane, Anthony N Karnezis, et al.
The Journal of Pathology|September 11, 2015
Dual loss of the SWI/SNF complex ATPases SMARCA4/BRG1 and SMARCA2/BRM is highly sensitive and specific for small cell carcinoma of the ovary, hypercalcaemic typeAnthony N Karnezis, Yemin Wang, Pilar Ramos, et al.
Breast Cancer Research and Treatment|January 3, 2021
A clinical calculator to predict disease outcomes in women with triple-negative breast cancerMei-Yin C Polley, Roberto A Leon-Ferre, Samuel Leung, et al.
Cancer Research|March 19, 2011
Targeting tumor hypoxia: suppression of breast tumor growth and metastasis by novel carbonic anhydrase IX inhibitorsYuanmei Lou, Paul C McDonald, Arusha Oloumi, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|March 15, 2016
An Immunohistochemical Algorithm for Ovarian Carcinoma TypingMartin Köbel, Kurosh Rahimi, Peter F Rambau, et al.
Cancer|April 1, 2021
Evaluation of treatment effects in patients with endometrial cancer and POLE mutations: An individual patient data meta-analysisJessica N McAlpine, Derek S Chiu, Remi A Nout, et al.
Pageof 13